|
〔1〕 FREEDMAN R. Schizophrenia〔J〕. N Engl J Med, 2003, 349(18):1738-1749.
〔2〕 CASTRO-NALLAR E, BENDALL M L, P?魪REZ-LOSADA M, et al. Composition, Taxonomy and Functional Diversity of the Oropharynx Microbiome in
Individuals with Schizophrenia and Controls〔J〕.PeerJ,2015,3: e1140.
〔3〕 SONG X, FAN X, SONG X, et al. Elevated Levels of
Adiponectin and Other Cytokines in Drug Naìve, First
Episode Schizophrenia Patients with Normal Weight〔J〕. Schizophr
Res,2013,150(1):269-273.
〔4〕 MONSOUR H P, QUIGLEY E M M. The Microbiome: What Will the Future Hold?〔J〕. Semin Liver Dis,2016, 36(4):354-359.
〔5〕 K?魡HRSTR?魻M C T, PARIENTE N, WEISS U. Intestinal Microbiota in
Health and Disease〔J〕. Nature,2016,535(7610):47.
〔6〕 AZIZ Q, DOR?魪 J, EMMANUEL A, et al. Gut Microbiota and
Gastrointestinal Health: Current Concepts and Future Directions〔J〕. Neurogastroenterol Motil,2013,25(1):4-15.
〔7〕 DONNELLY G F. The Impact of
Microbiota on Health and Illness〔J〕. Holist Nurs
Pract,2016,30(6):309-310.
〔8〕 王红兵. 精神分裂症的神经系统软体征〔J〕. 上海精神医学,1997(3):184-187.
〔9〕 李祥仁, 周爱华, 汤玲. 有遗传史的精神分裂症患者某些特征研究〔J〕. 临床精神医学杂志,2008,18(6):384-386.
〔10〕 尹春蕾,王楠,马莹莹,等.美洲大蠊提取物对精神疾病患者肠道菌群影响的研究〔J〕.大理大学学报,2021,6(8):50-53.
〔11〕 WANG Y, KASPER L H. The Role of Microbiome
in Central Nervous System Disorders〔J〕. Brain Behav
Immun, 2014,38:1-12.
〔12〕 JIANG H, LING Z, LING Z, et al. Altered Fecal Microbiota
Composition in Patients with Major Depressive Disorder〔J〕. Brain Behav Immun,2015,48: 186-194.
〔13〕 MIQUEL S, LECLERC M, MARTIN R, et al. Identification of Metabolic
Signatures Linked to Anti-Inflammatory Effects of Faecalibacterium prausnitzii〔J〕. mBio,2015,6(2):e00300-15.
|